{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Allogeneic_Natural_Killer_Cell_Line_MG4101",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A population of allogeneic, cytotoxic natural killer (NK) cells with potential antitumor activity. Allogeneic natural killer cell line MG4101 is derived from cells of a normal, healthy donor upon leukapheresis and activation.",
    "fdaUniiCode": "WX2ZW10GHO",
    "identifier": "C94209",
    "preferredName": "Allogeneic Natural Killer Cell Line MG4101",
    "semanticType": "Cell",
    "subclassOf": [
      "C129826",
      "C28676"
    ],
    "synonyms": [
      "Allogeneic NK Cell Line MG4101",
      "Allogeneic Natural Killer Cell Line MG4101",
      "MG-4101",
      "MG4101"
    ]
  }
}